Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3616937
Max Phase: Preclinical
Molecular Formula: C55H97N13O9
Molecular Weight: 1084.46
Molecule Type: Small molecule
Associated Items:
ID: ALA3616937
Max Phase: Preclinical
Molecular Formula: C55H97N13O9
Molecular Weight: 1084.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCC(=O)N[C@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O
Standard InChI: InChI=1S/C55H97N13O9/c1-6-7-8-9-10-11-12-13-14-15-19-22-47(69)61-39(23-28-56)49(71)65-43-27-32-60-48(70)44(33-36(2)3)66-51(73)41(25-30-58)62-50(72)40(24-29-57)64-55(77)46(35-38-20-17-16-18-21-38)68-54(76)45(34-37(4)5)67-52(74)42(26-31-59)63-53(43)75/h16-18,20-21,36-37,39-46H,6-15,19,22-35,56-59H2,1-5H3,(H,60,70)(H,61,69)(H,62,72)(H,63,75)(H,64,77)(H,65,71)(H,66,73)(H,67,74)(H,68,76)/t39-,40+,41+,42+,43+,44+,45+,46-/m1/s1
Standard InChI Key: KRIZEGOLKSXUEB-SBOMDUJTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1084.46 | Molecular Weight (Monoisotopic): 1083.7532 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. De Zoysa GH, Cameron AJ, Hegde VV, Raghothama S, Sarojini V.. (2015) Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides., 58 (2): [PMID:25495219] [10.1021/jm501084q] |
Source(1):